Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL
Clinical trial NCT05453669 · UNKNOWN
Trial details
- NCT number
- NCT05453669
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2024-06-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.